No Data
No Data
Unusual Options Activity: LCID, APLS and Others Attract Market Bets, LCID V/OI Ratio Reaches 199.4
EST May 16th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend
Apellis Pharmaceuticals: A Strong Buy on Syfovre's Performance and Market Potential
Apellis Pharmaceuticals Enters Into Senior Secured Credit Facility
Press Release: Apellis Pharmaceuticals Refinances Existing Debt With Up to $475 Million Non-Dilutive Credit Facility From Sixth Street
Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street -- Apellis received $375 million in funding at close, with ability to access
Apellis Pharmaceuticals Refinances Existing Debt With Up to $475 Million Non-Dilutive Credit Facility From Sixth Street
Apellis received $375 million in funding at close, with ability to access an additional $100 millionMajority of initial proceeds used to buy out existing SFJ Pharmaceuticals development liability Sign
Analysts Are Bullish on These Healthcare Stocks: Apellis Pharmaceuticals (APLS), TScan Therapeutics (TCRX)